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would be helpful to further elucidate this
point.
We must stress that we did not postulate
that CPB was the sole factor in the inflam-
matory response. Indeed, we documented
that surgical trauma leads to higher IL-6
levels in comparison with the use of CPB
without cardiac surgery.
We are in complete agreement that
there are a number of different factors af-
fecting IL-6 levels.
R. Prondzinsky
K. Werdan
Klinik und Poliklinik für Innere Medizin III
Universitätsklinik der Martin-Luther-
Universität Halle-Wittenberg, E.-Grube-Sr. 40,
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Radial artery for coronary artery
bypass grafting
To the Editor:
I would like to comment on a recent edi-
torial by Mussa and colleagues1 regarding
radial artery grafts for coronary artery by-
pass grafting. In their review of vasospasm
prophylaxis, they state that in addition to
antispasmodic agents during harvesting,
oral calcium-channel antagonists have been
recommended for as long as 1 year after
surgery to prevent delayed vasospasm.
However, my coworkers and I2 recently
reported a study evaluating the effects of
calcium-channel blockers in two random-
ized groups of comparable patients. We
found no differences between patients who
received diltiazem and those who did not,
especially regarding the development of
vascular spasm and angiographic patency 1
year after surgery. Similar results have
been published by other authors.3,4
This evidence is relevant when we con-
sider widespread use of the radial artery for
myocardial revascularization in patients
with different types of coronary disease.
Antispasmodic agents are known to have
adverse consequences, for example, in pa-
tients with acute hemodynamic instability
or with poor left ventricular function.
I agree with Mussa and colleagues1
when they state that there is accumulating
evidence that grafting the radial artery to
coronary targets with moderate stenosis
(70%) results in reduced patency. Angio-
graphic evidence from our study, with a
reproducible and objective method, dem-
onstrated that the degree of native coronary
stenosis was a strong predictor of radial
artery patency (P  .00001; odds ratio
1.08). When the degree of stenosis in the
native coronary artery is 70% or more, the
radial artery graft patency approaches that
of the internal thoracic artery at 1 postop-
erative year.2
I postulate that there is sufficient evi-
dence with which to recommend the use of
radial artery grafts for myocardial revascu-
larization in patients with significant coro-
nary artery stenosis (70%). Topical anti-
spasmodic agents should be used only
during harvesting the conduit. There is no
need for intravenous or oral calcium-channel
blockers, either intraoperatively or during the
first year of follow-up.
The definitive place of the radial artery
compared with other conduits for coronary
grafting will have to await the outcome of
ongoing randomized trials.
Sergio V. Moran, MD
Cardiovascular Surgery
Catholic University Hospital
Marcoleta 367
Santiago, Chile
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Reply to the Editor:
We thank Dr Moran for his interest in our
editorial concerning the use of radial arter-
ies (RA) as coronary bypass conduits.1 His
letter invites us to expand on two important
points covered in our article:
1. The use of oral calcium channel an-
tagonists as prophylaxis for delayed
vasospasm
2. Use of RA conduits as grafts to cor-
onary vessels with proximal steno-
ses in excess of 70% favours im-
proved long term patency
Concerning the first point, we would
agree that despite previous anecdotal rec-
ommendations there is no substantial evi-
dence for the use of oral calcium channel
antagonists to prevent delayed vasospasm
of RA conduits. Certainly, Gaudino and
associates2 randomized 120 patients re-
ceiving RA grafts to treatment with oral
calcium channel antagonist therapy or not,
and showed no difference in ischemic
symptoms, scintigraphic evidence of isch-
emia, or RA angiographic patency at 5
years. This is consistent with the data pub-
lished by Moran and coworkers.3
Concerning the second point, Moran
and colleagues elegantly demonstrated the
improved patency of RA conduits when
anastomosed to target vessels with high-
grade (70%) proximal stenoses. This
finding was subsequently confirmed in a
larger series with a longer interval to an-
giographic follow-up.4
Graft patency is influenced not only by
the biology and quality of the conduit but
also by physical factors such as luminal
blood pressure and runoff, which govern
luminal blood flow. The concept of com-
petitive flow suggests that graft flow is
influenced by native coronary flow. Royse
and colleagues5 have reported that blood
flow through composite arterial grafts (left
internal thoracic artery–RA T-grafts) fell
by 44% on reintroduction of native coro-
nary flow. Shear stress resulting from flow
activates endothelial nitric oxide synthase
and results in the production of nitric ox-
ide.6 Intuitively, grafted conduits should
fare better in conditions of poor native cor-
onary flow typified by high grade coronary
stenoses, as increased conduit blood flow
will contribute to improved nitric oxide
production.
Shafi Mussa, MA, MRCS
Bikram P. Choudhary, MRCS
David P. Taggart, MD(Hons), PhD, FRCS
Department of Cardiothoracic Surgery
John Radcliffe Hospital
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